Panamera Holdings Corp. Reports Worsening Liquidity Amidst Persistent Going Concern and Control Weaknesses
summarizeSummary
Panamera Holdings Corp. reported a dramatic increase in its working capital deficiency to over $4.1 million, alongside persistent going concern doubts and ineffective internal controls, signaling severe liquidity challenges.
check_boxKey Events
-
Working Capital Deficiency Worsens Significantly
The company's working capital deficiency dramatically increased from $59,931 at July 31, 2025, to $4,174,212 at January 31, 2026, primarily due to a $3.9 million related-party promissory note becoming a current liability.
-
Persistent Going Concern Warning
Management continues to express substantial doubt about the company's ability to continue as a going concern, citing insufficient financing to cover capital expenditures, working capital, and other cash requirements.
-
Continued Material Weaknesses in Internal Controls
Management concluded that disclosure controls and procedures were ineffective due to a lack of formal control processes for related party transactions and insufficient segregation of duties.
-
Critically Low Cash Reserves
Cash balances remain extremely low at $17,061 as of January 31, 2026, highlighting severe liquidity constraints.
auto_awesomeAnalysis
This quarterly report highlights a critical deterioration in Panamera Holdings Corp.'s liquidity, with the working capital deficiency expanding significantly. While the company's going concern warning and material weaknesses in internal controls were previously disclosed, the substantial increase in current liabilities, primarily from a related-party promissory note, presents an immediate and severe challenge to the company's financial stability. Investors should be highly concerned about the company's ability to fund ongoing operations given its minimal cash reserves and the continued need for external financing.
At the time of this filing, PHCI was trading at $6.30 on OTC in the Trade & Services sector, with a market capitalization of approximately $503.3M. The 52-week trading range was $0.25 to $10.30. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.